Inner Mongolia Furui Med Sci (300049) - Net Assets

Latest as of December 2025: CN¥2.79 Billion CNY ≈ $407.78 Million USD

Based on the latest financial reports, Inner Mongolia Furui Med Sci (300049) has net assets worth CN¥2.79 Billion CNY (≈ $407.78 Million USD) as of December 2025. Net assets (also known as shareholders' equity or book value) represent the difference between a company's total assets (CN¥3.44 Billion ≈ $503.22 Million USD) and total liabilities (CN¥652.21 Million ≈ $95.44 Million USD). This figure indicates the residual interest in the assets after deducting liabilities, essentially showing what would remain for shareholders if all assets were liquidated and all debts paid off. Check how resilient are Inner Mongolia Furui Med Sci's assets to evaluate the company's liquid asset resilience ratio.

Key Net Assets Metrics

Metric Value
Current Net Assets CN¥2.79 Billion
% of Total Assets 81.03%
Annual Growth Rate 17.77%
5-Year Change 54.33%
10-Year Change 52.66%
Growth Volatility 75.2

Inner Mongolia Furui Med Sci - Net Assets Trend (2006–2025)

This chart illustrates how Inner Mongolia Furui Med Sci's net assets have evolved over time, based on quarterly financial data. Also explore balance sheet size of Inner Mongolia Furui Med Sci for the complete picture of this company's asset base.

Annual Net Assets for Inner Mongolia Furui Med Sci (2006–2025)

The table below shows the annual net assets of Inner Mongolia Furui Med Sci from 2006 to 2025. For live valuation and market cap data, see 300049 company net worth.

Year Net Assets Change
2025-12-31 CN¥2.79 Billion
≈ $407.78 Million		 +30.96%
2024-12-31 CN¥2.13 Billion
≈ $311.38 Million		 +15.19%
2023-12-31 CN¥1.85 Billion
≈ $270.33 Million		 +1.18%
2022-12-31 CN¥1.83 Billion
≈ $267.18 Million		 +1.12%
2021-12-31 CN¥1.81 Billion
≈ $264.23 Million		 +11.77%
2020-12-31 CN¥1.62 Billion
≈ $236.40 Million		 +4.12%
2019-12-31 CN¥1.55 Billion
≈ $227.04 Million		 +2.49%
2018-12-31 CN¥1.51 Billion
≈ $221.53 Million		 -20.99%
2017-12-31 CN¥1.92 Billion
≈ $280.39 Million		 +4.96%
2016-12-31 CN¥1.83 Billion
≈ $267.13 Million		 +10.60%
2015-12-31 CN¥1.65 Billion
≈ $241.53 Million		 +80.37%
2014-12-31 CN¥915.10 Million
≈ $133.91 Million		 +22.25%
2013-12-31 CN¥748.53 Million
≈ $109.53 Million		 +2.03%
2012-12-31 CN¥733.64 Million
≈ $107.35 Million		 +4.35%
2011-12-31 CN¥703.08 Million
≈ $102.88 Million		 +2.28%
2010-12-31 CN¥687.42 Million
≈ $100.59 Million		 +336.57%
2009-12-31 CN¥157.46 Million
≈ $23.04 Million		 +12.86%
2008-12-31 CN¥139.52 Million
≈ $20.42 Million		 +9.20%
2007-12-31 CN¥127.76 Million
≈ $18.70 Million		 +2.62%
2006-12-31 CN¥124.50 Million
≈ $18.22 Million		 --

Equity Component Analysis

This analysis shows how different components contribute to Inner Mongolia Furui Med Sci's total equity over time. Equity components include common stock, retained earnings, additional paid-in capital, and other elements.

Equity Composition Insights

  • Retained earnings have grown by 1979.6% over the analyzed period, indicating profitable operations and earnings retention.

Current Equity Component Breakdown (December 2025)

Component Amount Percentage
Retained Earnings CN¥915.91 Million 46.30%
Common Stock CN¥264.98 Million 13.39%
Other Comprehensive Income CN¥329.92 Million 16.68%
Other Components CN¥467.51 Million 23.63%
Total Equity CN¥1.98 Billion 100.00%

Inner Mongolia Furui Med Sci Competitors by Market Cap

The table below lists competitors of Inner Mongolia Furui Med Sci ranked by their market capitalization.

Company Market Cap
Coty Inc
NYSE:COTY
 $1.95 Billion
Shenzhen Topband Co Ltd
SHE:002139
 $1.95 Billion
OPT Machine Vision Tech Co. Ltd. A
SHG:688686
 $1.96 Billion
Guobang Pharma Ltd
SHG:605507
 $1.96 Billion
WHA Corporation Public Company Limited
BK:WHA-R
 $1.95 Billion
Nuvoton Technology Corp
TW:4919
 $1.95 Billion
NCC AB (publ)
ST:NCC-B
 $1.95 Billion
NOS S.G.P.S. S.A.
LS:NOS
 $1.95 Billion

Equity Growth Attribution

This analysis shows how different factors contributed to changes in Inner Mongolia Furui Med Sci's equity between the two most recent reporting periods.

Equity Growth Insights

  • From 2024 to 2025, total equity changed from 1,747,683,972 to 1,978,323,925, a change of 230,639,953 (13.2%).
  • Net income of 154,089,068 contributed positively to equity growth.
  • Dividend payments of 2,287,429 reduced retained earnings.
  • Other comprehensive income increased equity by 85,437,926.

Equity Change Factors (2024 to 2025)

Factor Impact Contribution
Net Income CN¥154.09 Million +7.79%
Dividends Paid CN¥2.29 Million -0.12%
Other Comprehensive Income CN¥85.44 Million +4.32%
Other Changes CN¥-6.60 Million -0.33%
Total Change CN¥- 13.20%

Book Value vs Market Value Analysis

This analysis compares Inner Mongolia Furui Med Sci's book value (net assets) with its market value over time. The relationship between these values can provide insights into investor sentiment and company valuation.

Valuation Insights

  • Current price-to-book ratio: 6.70x
  • The company is trading at a significant premium to its book value, suggesting the market values its earnings potential, brand, or other intangibles highly.
  • The price-to-book ratio has decreased from 73.81x to 6.70x over the analyzed period, indicating reduced market premium.

Historical Price-to-Book Ratios

Date Book Value per Share Market Price P/B Ratio
2006-12-31 CN¥0.68 CN¥50.36 x
2007-12-31 CN¥0.69 CN¥50.36 x
2008-12-31 CN¥0.75 CN¥50.36 x
2009-12-31 CN¥0.84 CN¥50.36 x
2010-12-31 CN¥2.79 CN¥50.36 x
2011-12-31 CN¥2.82 CN¥50.36 x
2012-12-31 CN¥2.84 CN¥50.36 x
2013-12-31 CN¥2.91 CN¥50.36 x
2014-12-31 CN¥3.40 CN¥50.36 x
2015-12-31 CN¥5.12 CN¥50.36 x
2016-12-31 CN¥5.56 CN¥50.36 x
2017-12-31 CN¥5.63 CN¥50.36 x
2018-12-31 CN¥4.90 CN¥50.36 x
2019-12-31 CN¥5.15 CN¥50.36 x
2020-12-31 CN¥5.27 CN¥50.36 x
2021-12-31 CN¥5.85 CN¥50.36 x
2022-12-31 CN¥5.87 CN¥50.36 x
2023-12-31 CN¥5.88 CN¥50.36 x
2024-12-31 CN¥6.64 CN¥50.36 x
2025-12-31 CN¥7.52 CN¥50.36 x

Capital Efficiency Dashboard

This dashboard shows how efficiently Inner Mongolia Furui Med Sci utilizes its equity to generate returns, including Return on Equity (ROE) and its components based on the DuPont analysis framework.

Capital Efficiency Insights

  • Current Return on Equity (ROE): 7.79%
  • The company has moderate efficiency in generating returns from equity.
  • DuPont Analysis Breakdown:
  • • Net Profit Margin: 9.67%
  • • Asset Turnover: 0.46x
  • • Equity Multiplier: 1.74x
  • Recent ROE (7.79%) is below the historical average (8.53%), suggesting potential challenges in capital efficiency.

Historical Capital Efficiency Metrics

Year Return on Equity Net Profit Margin Asset Turnover Equity Multiplier Economic Value Added
2006 18.21% 18.59% 0.65x 1.51x CN¥10.19 Million
2007 17.64% 17.78% 0.63x 1.58x CN¥9.73 Million
2008 18.51% 18.28% 0.63x 1.60x CN¥11.87 Million
2009 21.86% 19.12% 0.72x 1.59x CN¥18.68 Million
2010 6.82% 22.28% 0.26x 1.16x CN¥-21.89 Million
2011 7.47% 17.40% 0.35x 1.24x CN¥-17.82 Million
2012 5.81% 10.09% 0.44x 1.31x CN¥-29.66 Million
2013 0.69% 0.94% 0.46x 1.60x CN¥-66.48 Million
2014 10.45% 13.51% 0.48x 1.59x CN¥3.73 Million
2015 6.84% 15.17% 0.30x 1.52x CN¥-42.42 Million
2016 8.28% 14.64% 0.34x 1.65x CN¥-25.19 Million
2017 4.09% 7.42% 0.33x 1.68x CN¥-88.42 Million
2018 2.66% 4.08% 0.41x 1.60x CN¥-97.94 Million
2019 3.29% 5.22% 0.37x 1.71x CN¥-88.49 Million
2020 4.58% 7.67% 0.35x 1.69x CN¥-73.30 Million
2021 6.28% 10.63% 0.36x 1.66x CN¥-56.49 Million
2022 6.33% 9.70% 0.40x 1.63x CN¥-56.65 Million
2023 6.56% 8.80% 0.44x 1.71x CN¥-53.17 Million
2024 6.48% 8.40% 0.44x 1.75x CN¥-61.48 Million
2025 7.79% 9.67% 0.46x 1.74x CN¥-43.74 Million

Industry Comparison

This section compares Inner Mongolia Furui Med Sci's net assets metrics with peer companies in the Biotechnology industry.

Industry Context

  • Industry: Biotechnology
  • Average net assets among peers: $2,109,695,154
  • Average return on equity (ROE) among peers: 0.18%

Peer Company Comparison

Company Net Assets Return on Equity Debt-to-Equity Market Cap
Inner Mongolia Furui Med Sci (300049) CN¥2.79 Billion 18.21% 0.23x $1.95 Billion
Shenzhen CAU Technology Co Ltd (000004) $108.47 Million -73.31% 2.66x $53.47 Million
Pacific Shuanglin Bio pharmacy Co Ltd (000403) $525.49 Million 14.76% 1.41x $1.66 Billion
Nanhua Bio Medicine Co Ltd (000504) $-14.51 Million 0.00% 0.00x $443.33 Million
Jiangsu Sihuan Bioengineering Co Ltd (000518) $660.31 Million 2.17% 0.39x $438.41 Million
Chengzhi Shareholding Co Ltd (000990) $930.16 Million 5.16% 0.80x $2.24 Billion
Hualan Biological EngineeringInc (002007) $3.88 Billion 15.17% 0.04x $3.86 Billion
Da An Gene Co Ltd of Sun Yat-Sen University (002030) $269.70 Million 9.75% 0.10x $1.19 Billion
Shanghai RAAS Blood Products Co Ltd Class A (002252) $12.48 Billion 6.70% 0.16x $5.40 Billion
Baolingbao Biology Co Ltd (002286) $703.11 Million 6.09% 0.47x $572.48 Million
Tibet Cheezheng Tibetan Medicine Co Ltd (002287) $1.55 Billion 15.33% 0.16x $1.90 Billion

About Inner Mongolia Furui Med Sci

SHE:300049 China Biotechnology
Market Cap
$1.95 Billion
CN¥13.34 Billion CNY
Market Cap Rank
#6369 Global
#1422 in China
Share Price
CN¥50.36
Change (1 day)
-0.36%
52-Week Range
CN¥29.85 - CN¥87.87
All Time High
CN¥87.87
Categories
Companies in China Biotechnology
About

Inner Mongolia Furui Medical Science Co., Ltd. engages in the production and sale of pharmaceutical drugs in China and internationally. The company operates in two segments: pharmaceutical production and sales; and diagnostic equipment R&D, production and sales. The pharmaceutical production and sales segment produces and sells products, such as Fufang Biejiaruangan tablets and shell fat capsules… Read more